Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522)

Kate Lynn; J. Bill; Jeannine Garnett; Isabelle Meaux; Xiao Yen Ma; Chad J. Creighton; Svetlana Bolshakov; Cedric Barriere; Laurent Debussche; Alexander J. Lazar; Bethany C. Prudner; Lucia Casadei; Danielle Braggio; Gonzalo Lopez; Abbie Zewdu; Hemant Bid; Lev Dina; Raphael E. Pollock

doi:10.1158/1078-0432.CCR-21-4243

Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522)

Kate Lynn, J. Bill, Jeannine Garnett, Isabelle Meaux, Xiao Yen Ma, Chad J. Creighton, Svetlana Bolshakov, Cedric Barriere, Laurent Debussche, Alexander J. Lazar, Bethany C. Prudner, Lucia Casadei, Danielle Braggio, Gonzalo Lopez, Abbie Zewdu, Hemant Bid, Lev Dina, Raphael E. Pollock

Pathology, Anatomical

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

In the original version of this article (1), the Lipo224B and LPS141 panels in Fig. 1A were inadvertently duplicated. The figure has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.

Original language	English (US)
Pages (from-to)	431
Number of pages	1
Journal	Clinical Cancer Research
Volume	28
Issue number	2
DOIs	https://doi.org/10.1158/1078-0432.CCR-21-4243
State	Published - Jan 15 2022

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1158/1078-0432.CCR-21-4243

Cite this

Lynn, K., Bill, J., Garnett, J., Meaux, I., Ma, X. Y., Creighton, C. J., Bolshakov, S., Barriere, C., Debussche, L., Lazar, A. J., Prudner, B. C., Casadei, L., Braggio, D., Lopez, G., Zewdu, A., Bid, H., Dina, L., & Pollock, R. E. (2022). Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522). Clinical Cancer Research, 28(2), 431. https://doi.org/10.1158/1078-0432.CCR-21-4243

Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522). / Lynn, Kate; Bill, J.; Garnett, Jeannine et al.
In: Clinical Cancer Research, Vol. 28, No. 2, 15.01.2022, p. 431.

Research output: Contribution to journal › Comment/debate › peer-review

Lynn, K, Bill, J, Garnett, J, Meaux, I, Ma, XY, Creighton, CJ, Bolshakov, S, Barriere, C, Debussche, L, Lazar, AJ, Prudner, BC, Casadei, L, Braggio, D, Lopez, G, Zewdu, A, Bid, H, Dina, L & Pollock, RE 2022, 'Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522)', Clinical Cancer Research, vol. 28, no. 2, pp. 431. https://doi.org/10.1158/1078-0432.CCR-21-4243

@article{76e8a02ca41e480b8b827410ab975057,

title = "Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522)",

abstract = "In the original version of this article (1), the Lipo224B and LPS141 panels in Fig. 1A were inadvertently duplicated. The figure has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.",

author = "Kate Lynn and J. Bill and Jeannine Garnett and Isabelle Meaux and Ma, {Xiao Yen} and Creighton, {Chad J.} and Svetlana Bolshakov and Cedric Barriere and Laurent Debussche and Lazar, {Alexander J.} and Prudner, {Bethany C.} and Lucia Casadei and Danielle Braggio and Gonzalo Lopez and Abbie Zewdu and Hemant Bid and Lev Dina and Pollock, {Raphael E.}",

year = "2022",

month = jan,

day = "15",

doi = "10.1158/1078-0432.CCR-21-4243",

language = "English (US)",

volume = "28",

pages = "431",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "2",

}

TY - JOUR

T1 - Erratum

T2 - SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522)

AU - Lynn, Kate

AU - Bill, J.

AU - Garnett, Jeannine

AU - Meaux, Isabelle

AU - Ma, Xiao Yen

AU - Creighton, Chad J.

AU - Bolshakov, Svetlana

AU - Barriere, Cedric

AU - Debussche, Laurent

AU - Lazar, Alexander J.

AU - Prudner, Bethany C.

AU - Casadei, Lucia

AU - Braggio, Danielle

AU - Lopez, Gonzalo

AU - Zewdu, Abbie

AU - Bid, Hemant

AU - Dina, Lev

AU - Pollock, Raphael E.

PY - 2022/1/15

Y1 - 2022/1/15

N2 - In the original version of this article (1), the Lipo224B and LPS141 panels in Fig. 1A were inadvertently duplicated. The figure has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.

AB - In the original version of this article (1), the Lipo224B and LPS141 panels in Fig. 1A were inadvertently duplicated. The figure has been corrected in the latest online HTML and PDF versions of the article. The authors regret the error.

UR - http://www.scopus.com/inward/record.url?scp=85123661956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85123661956&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-21-4243

DO - 10.1158/1078-0432.CCR-21-4243

M3 - Comment/debate

C2 - 35045964

AN - SCOPUS:85123661956

SN - 1078-0432

VL - 28

SP - 431

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 2

ER -

Erratum: SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma (Clin Cancer Res (2016)22 (1150-1160) DOI: 10.1158/1078-0432.CCR-15-1522)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this